MAM
MPM Asset Management Portfolio holdings
AUM
$43.3M
This Quarter Return
+1.79%
1 Year Return
-54.44%
3 Year Return
+14.05%
5 Year Return
-29.8%
10 Year Return
-11.6%
AUM
$204M
AUM Growth
+$204M
(-15%)
Cap. Flow
-$39.2M
Cap. Flow
% of AUM
-19.21%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
10
New
1
Increased
–
Reduced
–
Closed
2
Top Buys
| 1 |
ADAP
Adaptimmune Therapeutics
ADAP
|
$5.82M |
Top Sells
| 1 |
AMYT
Amryt Pharma plc American Depositary Shares
AMYT
|
$38.9M |
| 2 |
TCRR
TCR2 Therapeutics Inc. Common Stock
TCRR
|
$6.08M |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Entrada Therapeutics
TRDA
$208M
| $67M | 32.86% | 4,425,784 | – | – |
|
2
Dyne Therapeutics
DYN
$1.92B
| $55.7M | 27.32% | 4,951,303 | – | – |
|
3
iTeos Therapeutics
ITOS
| $36.3M | 17.78% | 2,738,785 | – | – |
|
4
Repare Therapeutics
RPTX
$71.7M
| $23.7M | 11.64% | 2,242,636 | – | – |
|
5
Werewolf Therapeutics
HOWL
$59.9M
| $13.1M | 6.41% | 4,284,172 | – | – |
|
|
ADAP
6
Adaptimmune Therapeutics
ADAP
$15.6M
| $5.82M | 2.85% | +6,287,101 | New | +$5.82M |
|
|
HARP
7
DELISTED
Harpoon Therapeutics, Inc. Common Stock
HARP
| $2.22M | 1.09% | 3,131,388 | – | – |
|
|
ONCR
8
DELISTED
Oncorus, Inc.
ONCR
| $115K | 0.06% | 2,849,464 | – | – |
|
|
TCRR
9
DELISTED
TCR2 Therapeutics Inc. Common Stock
TCRR
| – | – | -4,050,865 | Closed | -$6.08M |
|
|
AMYT
10
DELISTED
Amryt Pharma plc American Depositary Shares
AMYT
| – | – | -2,668,843 | Closed | -$38.9M |
|